Fatigue is a common side effect of Lipitor, a medication used to lower cholesterol levels and prevent heart disease. According… https://www.Drugchatter.com/chat/16688/do-you-often-feel-tired-after-taking-lipitor/
DrugChatter: Do you often feel tired after taking lipitor? Read Post »
Yervoy, also known as ipilimumab, is a medication used to treat melanoma. It has been on the market since March 2011 and… https://www.Drugchatter.com/chat/23203/any-news-on-yervoy-s-patent-expiration/
DrugChatter: Any news on yervoy s patent expiration? Read Post »
Biosimilar timelines aren’t linear—so why are outreach strategies?
If you’re trying to reach biosimilar manufacturers, you’re probably doing it the hard way: waiting until a patent expiry date is “close enough,” then assuming the commercial and technic…
Drug patents in Europe: the clock starts ticking the moment you file—and it rarely ends cleanly.
If you’re building a pipeline, underwriting risk, or planning market entry in Europe, you already know the headline number: patents can last up to 20 years…
European Drug Patents: Exactly How Long Protection Lasts — and Where It Breaks Down Read Post »
Drug discovery timelines are getting longer—and the cost of waiting is rising. The industry has spent years optimizing molecules, assays, and trials, but the bottleneck is increasingly coordination: turning fragmented data, shifting hypotheses, and ite…
Slash drug discovery timelines with GPT-Rosalind Read Post »
The “Patent Expiration Cliff” Isn’t a Cliff—It’s a Calendar. Here’s Why Market Access Teams Should Act Months Earlier.
If you work in commercial market access, you’ve seen it: the sudden scramble when a branded product’s exclusivity is about to end. Co…
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
If you’ve ever watched a first-filer launch turn into a slower-than-expected climb, there’s a quiet reason that shows up again and again: authorized generics.
In plain terms…
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits Read Post »
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
The generic drug market is often described as a race—but it’s really a calendar. And in today’s regulatory environment, the “finish line” isn’t just patent expira…
Unlocking the Hidden Clock: How Precise Mapping of Regulatory Exclusivities Can Accelerate Generic Drug Entry
In the complex world of pharmaceutical innovation and market competition, timing is everything. Yet, for many stakeholders—manufacturers, inve…
Lipitor (atorvastatin) and SSRIs (selective serotonin reuptake inhibitors) are commonly prescribed medications for cholesterol… https://www.Drugchatter.com/chat/24497/what-are-the-potential-health-risks-of-lipitor-ssri-interaction-in-the-elderly/
Get new actionable insights and updates from BiotechBlog
